Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Albaha Barqawi to Humans

This is a "connection" page, showing publications Albaha Barqawi has written about Humans.

 
Connection Strength
 
 
 
0.163
 
  1. Barqawi AB, Rodrigues Pessoa R, Crawford ED, Al-Musawi M, MacDermott T, O'Donell C, Kendl RM. Boosting immune response with GM-CSF optimizes primary cryotherapy outcomes in the treatment of prostate cancer: a prospective randomized clinical trial. Prostate Cancer Prostatic Dis. 2021 09; 24(3):750-757.
    View in: PubMed
    Score: 0.024
  2. Barqawi A, Pessoa RR, Al-Musawi M, MacDermott T, O'Donnell CI. The Impact of Performing a 3D Mapping Biopsy Prior to Primary Cryotherapy for the Treatment of Prostate Cancer. Urology. 2020 10; 144:171-176.
    View in: PubMed
    Score: 0.023
  3. Eid K, Krughoff K, Stoimenova D, Smith D, Phillips J, O'Donnell C, Barqawi A. Validation of the Urgency, Weak stream, Incomplete emptying, and Nocturia (UWIN) score compared with the American Urological Association Symptoms Score in assessing lower urinary tract symptoms in the clinical setting. Urology. 2014 Jan; 83(1):181-5.
    View in: PubMed
    Score: 0.014
  4. Siomos VJ, Barqawi A. The current status of cryotherapy and high-intensity focused ultrasound in the treatment of low-grade prostate cancer. Rev Recent Clin Trials. 2011 May; 6(2):171-6.
    View in: PubMed
    Score: 0.012
  5. Crawford ED, Barqawi A. Targeted focal therapy: a minimally invasive ablation technique for early prostate cancer. Oncology (Williston Park). 2007 Jan; 21(1):27-32; discussion 33-4, 39.
    View in: PubMed
    Score: 0.009
  6. Barqawi A, Crawford ED. Testosterone replacement therapy and the risk of prostate cancer. Is there a link? Int J Impot Res. 2006 Jul-Aug; 18(4):323-8.
    View in: PubMed
    Score: 0.008
  7. Barqawi A, O'Donnell C, Kumar R, Koul H, Crawford ED. Correlation between LUTS (AUA-SS) and erectile dysfunction (SHIM) in an age-matched racially diverse male population: data from the Prostate Cancer Awareness Week (PCAW). Int J Impot Res. 2005 Jul-Aug; 17(4):370-4.
    View in: PubMed
    Score: 0.008
  8. Barqawi A, Crawford ED. Focal therapy in prostate cancer: future trends. BJU Int. 2005 Feb; 95(3):273-4.
    View in: PubMed
    Score: 0.008
  9. Crawford ED, Barqawi A. Intermediate- to high-risk prostate cancer patient treated with radiation therapy. Oncology (Williston Park). 2004 Aug; 18(9):1105-10.
    View in: PubMed
    Score: 0.008
  10. Barqawi A, Thompson IM, Crawford ED. Prostate cancer chemoprevention: an overview of United States trials. J Urol. 2004 Feb; 171(2 Pt 2):S5-8; discussion S9.
    View in: PubMed
    Score: 0.007
  11. Barqawi A, Gamito E, O'Donnell C, Crawford ED. Herbal and vitamin supplement use in a prostate cancer screening population. Urology. 2004 Feb; 63(2):288-92.
    View in: PubMed
    Score: 0.007
  12. Barqawi A, Akduman B, Abouelfadel Z, Robischon M, Crawford ED. The use of flutamide as a single antiandrogen treatment for hormone-refractory prostate cancer. BJU Int. 2003 Nov; 92(7):695-8.
    View in: PubMed
    Score: 0.007
  13. Barqawi AZ, Blyth B, Jordan GH, Ehrlich RM, Koyle MA. Role of laparoscopy in patients with previous negative exploration for impalpable testis. Urology. 2003 Jun; 61(6):1234-7; discussion 1237.
    View in: PubMed
    Score: 0.007
  14. Vigen R, O'Donnell CI, Barón AE, Grunwald GK, Maddox TM, Bradley SM, Barqawi A, Woning G, Wierman ME, Plomondon ME, Rumsfeld JS, Ho PM. Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels. JAMA. 2013 Nov 06; 310(17):1829-36.
    View in: PubMed
    Score: 0.004
  15. Narayanan R, Werahera PN, Barqawi A, Crawford ED, Shinohara K, Simoneau AR, Suri JS. Adaptation of a 3D prostate cancer atlas for transrectal ultrasound guided target-specific biopsy. Phys Med Biol. 2008 Oct 21; 53(20):N397-406.
    View in: PubMed
    Score: 0.003
  16. Shen F, Shinohara K, Kumar D, Khemka A, Simoneau AR, Werahera PN, Li L, Guo Y, Narayanan R, Wei L, Barqawi A, Crawford ED, Davatzikos C, Suri JS. Three-dimensional sonography with needle tracking: role in diagnosis and treatment of prostate cancer. J Ultrasound Med. 2008 Jun; 27(6):895-905.
    View in: PubMed
    Score: 0.002
  17. Flaig T, Crawford ED, Kavanagh B, Lucia S, La Rosa F, Barqawi A, Crighton F, Glodé LM. Prostate cancer in a man with multiple previous cancers. Oncology (Williston Park). 2007 Apr; 21(5):611-4.
    View in: PubMed
    Score: 0.002
  18. Flaig TW, Barqawi A, Miller G, Kane M, Zeng C, Crawford ED, Glodé LM. A phase II trial of dexamethasone, vitamin D, and carboplatin in patients with hormone-refractory prostate cancer. Cancer. 2006 Jul 15; 107(2):266-74.
    View in: PubMed
    Score: 0.002
  19. Kumar RJ, Barqawi A, Crawford ED. Preventing and treating the complications of hormone therapy. Curr Urol Rep. 2005 May; 6(3):217-23.
    View in: PubMed
    Score: 0.002
  20. Ziada A, Barqawi A, Glode LM, Varella-Garcia M, Crighton F, Majeski S, Rosenblum M, Kane M, Chen L, Crawford ED. The use of trastuzumab in the treatment of hormone refractory prostate cancer; phase II trial. Prostate. 2004 Sep 01; 60(4):332-7.
    View in: PubMed
    Score: 0.002
  21. Glode LM, Barqawi A, Crighton F, Crawford ED, Kerbel R. Metronomic therapy with cyclophosphamide and dexamethasone for prostate carcinoma. Cancer. 2003 Oct 15; 98(8):1643-8.
    View in: PubMed
    Score: 0.002
  22. Lowe JB, Furness PD, Barqawi AZ, Koyle MA. Surgical management of the neuropathic bladder. Semin Pediatr Surg. 2002 May; 11(2):120-7.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2022 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)